The predicted share price (Closing Price) for Solara Active Pharma Sciences Ltd for tomorrow (2026-04-13) is ₹403.95 which is 5.18% lower than today’s share price of ₹426.00
Solara Active Pharma Sciences Ltd – Investor Insights
Valuation StatusiCompares the stock's intrinsic value (calculated from fundamentals like earnings, book value, and growth) with the current market price (CMP). Undervalued = potential buying opportunity. Overvalued = the market may be pricing in too much optimism.
Overvalued
Intrinsic ₹220.30 vs CMP ₹426.00 (-48.3%)
Market RegimeiShows whether the stock is in an uptrend (bullish) or downtrend (bearish) based on its Exponential Moving Average (EMA). When price is above EMA → bullish momentum. Below EMA → bearish pressure. This affects how our model adjusts volatility and predictions.
▼ Bearish
Price/EMA: 0.816 · EMA(252): ₹522.21
VolatilityiMeasures how much the stock price swings. Low (<25%) = stable, predictable price movement. Moderate (25-40%) = normal for most stocks. High (>40%) = large daily swings, higher risk. The "recent trend" shows if volatility is currently increasing or decreasing compared to its historical average.
43.5% annualized
Risk: High · Recent trend: Stable
Trend MemoryiThe Hurst Exponent measures whether price movements tend to continue (trending) or reverse (mean-reverting). Above 0.55 = momentum persists, recent trends likely to continue. Below 0.45 = price tends to snap back after big moves. Around 0.5 = random walk, past moves don't predict future direction.
Random walk
Hurst exponent: 0.510
Projected CAGRiCompound Annual Growth Rate — the average yearly return if the stock reaches our projected price target. 5Y and 10Y show different time horizons. Higher CAGR = faster expected growth. Negative CAGR = the model projects the stock may decline from current levels.
-0.2%5Y+0.1%10Y
Historical drift: -21.2% annualized
Risk-Reward RatioiCompares your potential upside (to intrinsic value) against potential downside (to fundamental floor). Above 2x = favorable risk-reward, potential gain is at least double the potential loss. Below 1x = unfavorable, you risk losing more than you could gain. A negative value means the stock is already above intrinsic value.
-0.50x
Upside -48.3% vs downside 97.2% · Unfavourable
Margin of SafetyiA concept from value investing (Benjamin Graham). It measures how much cheaper the stock is compared to its intrinsic value. Positive margin = you're buying below fair value (safety cushion). Negative margin = you're paying more than the stock is fundamentally worth. Most value investors look for at least 15-25% margin of safety.
-93.4%
No margin
Model ConfidenceiShows how reliable our predictions are for this stock. Based on the model's average prediction error over the last 90 days. Low error = high confidence. Also shows data coverage — more data points over longer periods produce more reliable projections. The model self-learns by adjusting parameters every 7 days.
Low
Avg error: 15.56% · 586 data points over 598 days
Fundamental FlooriThe lowest price the stock is expected to reach under normal market conditions, based on book value and financial strength (ROE, ROCE, debt ratios). A very low floor relative to CMP means the company has limited tangible asset backing at current prices. In extreme market crashes, prices can temporarily breach this level.
₹12.00
(97.2% below CMP)
52-Week Range
iShows the stock's lowest and highest closing prices over the past year (~252 trading days). The marker shows where today's price sits within that range. Near the low = potential value opportunity or ongoing weakness. Near the high = momentum or possible overextension.
₹426.00
₹622.00
CMP: ₹426.000% into range31.5% below 52W high
Monthly Return DistributioniBased on historical monthly returns (~21 trading days per month). Shows how many months the stock went up vs down, the best and worst single-month returns, and the win rate. A win rate above 55% with a positive average return indicates consistent performance. High best/worst spread = volatile returns.
Convergence TimelineiShows how long the model expects the stock price to take to converge toward its intrinsic value. The model uses a mathematical convergence rate that pulls the projected price toward intrinsic value gradually. Milestones show the expected price at 25%, 50%, 75%, and 100% convergence. For overvalued stocks, convergence means the price may decline toward intrinsic value.
Target: ₹220.30 in ~5.0 years (2031)
Now ₹42625% ₹37550% ₹32375% ₹272Target ₹220
Gap: 48.3% downward · Model convergence rate: 5.0 years
What this means: Solara Active Pharma Sciences Ltd appears overvalued by 48.3% relative to intrinsic value. The stock is currently in a bearish regime (price below EMA). Volatility is high (43.5% annualized), implying wider price swings and higher risk.
Solara Active Pharma Sciences Ltd Year-Wise Share Price Target (2027–2036)
Year
Projected Price (₹)
Growth %
CAGR
2027
419.62
-1.5%
-1.5%
Month
Projected Price (₹)
Jan
419.34
Feb
418.66
Mar
412.68
Apr
412.12
May
412.67
Jun
411.49
Jul
410.73
Aug
412.14
Sep
412.27
Oct
411.64
Nov
410.06
Dec
419.62
2028
424.13
-0.4%
-0.2%
Month
Projected Price (₹)
Jan
421.73
Feb
418.65
Mar
417.78
Apr
418.85
May
414.57
Jun
420.84
Jul
422.51
Aug
420.30
Sep
418.05
Oct
414.53
Nov
418.33
Dec
424.13
2029
426.09
+0.0%
+0.0%
Month
Projected Price (₹)
Jan
426.85
Feb
429.57
Mar
428.31
Apr
435.60
May
433.80
Jun
430.29
Jul
430.06
Aug
428.77
Sep
433.16
Oct
432.15
Nov
428.13
Dec
426.09
2030
415.89
-2.4%
-0.6%
Month
Projected Price (₹)
Jan
421.03
Feb
425.11
Mar
430.32
Apr
425.82
May
419.38
Jun
413.53
Jul
411.34
Aug
409.55
Sep
405.04
Oct
409.25
Nov
414.43
Dec
415.89
2031
421.09
-1.2%
-0.2%
Month
Projected Price (₹)
Jan
418.27
Feb
414.78
Mar
414.60
Apr
414.74
May
416.99
Jun
415.81
Jul
418.24
Aug
420.32
Sep
423.52
Oct
421.74
Nov
420.66
Dec
421.09
2032
421.11
-1.1%
-0.2%
Month
Projected Price (₹)
Jan
417.36
Feb
417.62
Mar
418.10
Apr
425.62
May
425.39
Jun
426.75
Jul
419.05
Aug
416.92
Sep
414.30
Oct
417.76
Nov
418.31
Dec
421.11
2033
417.12
-2.1%
-0.3%
Month
Projected Price (₹)
Jan
420.39
Feb
424.02
Mar
423.60
Apr
421.58
May
421.39
Jun
420.13
Jul
421.54
Aug
420.99
Sep
419.45
Oct
421.02
Nov
421.45
Dec
417.12
2034
423.95
-0.5%
-0.1%
Month
Projected Price (₹)
Jan
422.15
Feb
423.39
Mar
421.73
Apr
424.93
May
428.11
Jun
427.58
Jul
424.62
Aug
435.03
Sep
427.25
Oct
432.37
Nov
429.22
Dec
423.95
2035
437.33
+2.7%
+0.3%
Month
Projected Price (₹)
Jan
425.35
Feb
427.71
Mar
431.79
Apr
433.56
May
433.13
Jun
430.27
Jul
430.79
Aug
428.98
Sep
430.43
Oct
435.65
Nov
437.35
Dec
437.33
2036
430.82
+1.1%
+0.1%
Month
Projected Price (₹)
Jan
433.63
Feb
432.96
Mar
437.90
Apr
438.07
May
440.28
Jun
437.86
Jul
436.00
Aug
434.50
Sep
433.59
Oct
437.55
Nov
436.85
Dec
430.82
Solara Active Pharma Sciences Ltd Stock Price Analysis
Avg Error (MAPE)iMean Absolute Percentage Error — the average difference between predicted and actual prices, expressed as a percentage. Lower is better. Below 2% = excellent, 2-5% = good, above 5% = the model struggles with this stock.
4.58%
Direction AccuracyiHow often the model correctly predicted whether the price would go up or down the next day. Above 55% = good (better than a coin flip). Above 60% = strong. This matters more than exact price accuracy for trading decisions.
60.3%
Avg Error (₹)iThe average rupee difference between predicted and actual closing prices. For a ₹100 stock, an error of ₹2 means predictions are typically off by about 2%. This gives you a sense of the prediction's precision in absolute terms.
₹25.70
PredictionsiTotal number of daily predictions made for this stock. More predictions = more data for accuracy metrics. The model self-learns and adjusts its parameters every 7 days, so accuracy typically improves over time.
312
Solara Active Pharma Sciences Ltd – Historical Performance vs Predictions
Solara Active Pharma Sciences Ltd – 3-Month Price Forecast
Will Solara Active Pharma Sciences Ltd share price increase tomorrow?
Solara Active Pharma Sciences Ltd share price is expected to decrease to ₹403.95 on 2026-04-13, which is 5.18% lower than today's price of ₹426.00. This prediction is based on our AI-powered GFBM model.
What is the intrinsic value of Solara Active Pharma Sciences Ltd?
Solara Active Pharma Sciences Ltd intrinsic value is ₹220.30, which is 48.29% below the current price of ₹426.00. This suggests the stock is currently overvalued.
What is the share price target of Solara Active Pharma Sciences Ltd in 2027?
Solara Active Pharma Sciences Ltd share price target for 2027 is projected to reach ₹419.62 by year-end (range: ₹410.06 to ₹419.62), representing a -1.50% decrease from the current price of ₹426.00.
What is the share price target of Solara Active Pharma Sciences Ltd in 2028?
Solara Active Pharma Sciences Ltd share price target for 2028 is projected to reach ₹424.13 by year-end (range: ₹414.53 to ₹424.13), representing a -0.44% decrease from the current price of ₹426.00.
What is the share price target of Solara Active Pharma Sciences Ltd in 2029?
Solara Active Pharma Sciences Ltd share price target for 2029 is projected to reach ₹426.09 by year-end (range: ₹426.09 to ₹435.60), representing a 0.02% increase from the current price of ₹426.00.
Should I buy Solara Active Pharma Sciences Ltd stock now?
Based on current analysis, Solara Active Pharma Sciences Ltd appears to be a consider reviewing your position candidate. Intrinsic value is ₹220.30 vs CMP ₹426.00. This is not investment advice — consult a SEBI-registered advisor before making investment decisions.
What is the fundamental floor price for Solara Active Pharma Sciences Ltd?
The fundamental floor price for Solara Active Pharma Sciences Ltd is ₹12.00, calculated from book value and financial strength metrics (ROE, ROCE, debt-to-equity, interest coverage). This is the theoretical minimum price under normal market conditions.
The projected stock prices are provided for informational purposes only and do not constitute investment advice or recommendations. Past performance of securities is not indicative of future results. Getaka Financial Technology is not responsible for any investment decisions made on the basis of this information. Investors are advised to seek independent financial advice from a SEBI-registered investment advisor before making any investment decisions. Investments in the securities market are subject to market risks. Please read all associated offer documents and terms carefully before investing.